Equity Trader Departs CDC In New York

  • 19 Aug 2003
Email a colleague
Request a PDF

Jason Megson, an equity derivatives trader at CDC IXIS North America in New York, has left the firm. Megson, who could not be reached, is not yet thought to have joined a competitor. His departure follows Quincy Evans and Christophe Thomas, who co-headed the firm's convertible arbitrage effort (DW, 7/13). Janine Shagoury, spokeswoman in New York, declined comment.

Megson reported to Vuk Bulajic, head of equity derivatives at CDC in New York, who was on vacation and could not be reached.

  • 19 Aug 2003

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 13 Mar 2017
1 JPMorgan 94,925.33 384 8.39%
2 Citi 87,531.58 331 7.74%
3 Bank of America Merrill Lynch 84,341.49 288 7.46%
4 Barclays 75,288.19 241 6.66%
5 Goldman Sachs 68,504.71 208 6.06%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 14 Mar 2017
1 Bank of America Merrill Lynch 10,650.87 23 11.13%
2 Deutsche Bank 8,169.49 17 8.53%
3 HSBC 6,243.46 23 6.52%
4 Citi 4,355.35 13 4.55%
5 SG Corporate & Investment Banking 4,273.37 17 4.46%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • 21 Mar 2017
1 JPMorgan 5,440.56 17 10.74%
2 Deutsche Bank 4,468.97 23 8.82%
3 UBS 3,742.72 17 7.39%
4 Citi 3,393.89 23 6.70%
5 Goldman Sachs 3,360.93 18 6.63%